Public trial registry of the CCC-Munich

Trial U31287-A-U203 DAIICHI

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
U31287-A-U203 DAIICHI
World
Full title
:

Randomized, Placebo-Controlled, Double-Blind Phase 2 Study
of Patritumab (U3-1287) in Combination with Cetuximab plus
Platinum-Based Therapy in First Line Setting in Subjects with
Recurrent or Metastatic Squamous Cell Carcinoma of the Head
and Neck

World
EudraCT number
:
World
Responsible organization
:
Strahlentherapie Lmu
Indications
Classification Code Description
- C00-C14, C30.-,C33 ENT tumor
Trial design
World
Trial type
:
Interventional
World
Blinding type
:
Double blinded
World
Phase
:
II
Status
World
Status
:
Trial finished
Votes
World
Institutional review board - vote
:
Positive
Initiiation & lock
World
Date of lock (planned / actual)
:
Unknown / 2017-07-17
Therapy
World
Therapy line
:
1
Participants The lead of this trial has not explicitely given their approval for publishing the contact information of the principal investigators or specific contact persons.